Libânio D, Pimentel-Nunes P, Afonso L P, Henrique R, Dinis-Ribeiro M
CINTESIS - Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.
Gastroenterology Department, Portuguese Institute of Oncology of Porto (IPO-Porto), Porto, Portugal.
GE Port J Gastroenterol. 2017 Jan;24(1):31-39. doi: 10.1159/000450874. Epub 2016 Nov 30.
Endoscopic submucosal dissection (ESD) is an effective treatment for gastric superficial neoplasms and curative in 80-85% of the patients. The aims of this study were to identify risk factors for non-curative resection and metachronous development, and to evaluate patient management and outcome after non-curative resection.
In this single-centre study, the outcome of consecutive patients submitted to gastric ESD was assessed during a minimum follow-up of 18 months. Univariate analysis and multivariate logistic regression were performed to identify risk factors.
ESD was performed in 194 lesions (164 patients) between 2005 and 2014. The median follow-up was 40 months. En bloc and complete resection rates were 95.3 and 93.8%, respectively. Male sex, larger tumor size, longer procedural time, and more advanced histology were associated with a non-curative resection ( < 0.05), but only carcinoma detected in biopsies before resection was identified as a significant risk factor on multivariate analysis. Metachronous lesions occurred in 18.4%, and the incidence rate was 4.7 lesions/100 person-years. Older age at diagnosis was identified as the only predictor of metachronous development in logistic regression. In the non-curative resection group, survival did not differ between patients allocated to surveillance and those submitted to gastrectomy; 75% of gastrectomy specimens showed no residual lesion.
The risk factors identified for non-curative resection help to improve patient selection and patient information. Older patients had an increased risk for the development of metachronous lesions. In patients with non-curative resections, individualized patient management and surveillance seems to be an adequate option in selected cases.
内镜黏膜下剥离术(ESD)是治疗胃浅表肿瘤的一种有效方法,80 - 85%的患者可实现治愈。本研究的目的是确定非治愈性切除和异时性发展的危险因素,并评估非治愈性切除后的患者管理及预后。
在这项单中心研究中,对连续接受胃ESD治疗的患者进行了至少18个月的随访,评估其预后。采用单因素分析和多因素逻辑回归来确定危险因素。
2005年至2014年间,对194个病变(164例患者)实施了ESD。中位随访时间为40个月。整块切除率和完全切除率分别为95.3%和93.8%。男性、肿瘤较大、手术时间较长以及组织学分级较高与非治愈性切除相关(P < 0.05),但多因素分析仅将切除前活检中检测到的癌确定为显著危险因素。异时性病变发生率为18.4%,发病率为4.